Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System.
Atypical presentation of multiple sclerosis.
Gender differences in caregiver strain, needs for support, social support, and quality of life among spousal caregivers of persons with multiple sclerosis.
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
Systematic review of correlates and determinants of physical activity in persons with multiple sclerosis.
The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases.
Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
Single-Institution Retrospective Series of Gamma Knife Radiosurgery in the Treatment of Multiple Sclerosis-Related Trigeminal Neuralgia: Factors that Predict Efficacy.
Psychiatric diagnoses and cognitive impairment in pediatric multiple sclerosis.
Relative changes in ankle and hip control during bilateral joint movements in persons with multiple sclerosis.
C9ORF72 repeat expansion not detected in patients with multiple sclerosis.
The MoSt Project--More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.
Restless legs syndrome as the initial presentation of multiple sclerosis.
Increase in multiple sclerosis activity after assisted reproduction technology.
HLA-DRB1*15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer.
Inadequacy of Clinical Trial Designs and Data to Control for the Confounding Impact of Race/Ethnicity in Response to Treatment in Multiple Sclerosis.
Bisphenol-A Impairs Myelination Potential During Development in the Hippocampus of the Rat Brain.
A 17 year-old girl with a demyelinating disease requiring mechanical ventilation: a case report.
Intractable vomiting as an initial presentation of lupus-related neuromyelitis optica.
Natural antisense RNAs are involved in the regulation of CD45 expression in autoimmune diseases.
Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever.
Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
Perceived Cognitive Difficulties and Cognitive Test Performance as Predictors of Employment Outcomes in People with Multiple Sclerosis.
Implications for multiple sclerosis in the era of the Affordable Care Act: an evolving treatment paradigm.
Pages
« first
‹ previous
…
592
593
594
595
596
597
598
599
600
…
next ›
last »